Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Autor: Usha K Raina, Basudeb Ghosh, Anisha Seth, Anika Gupta, Supriya Arora
Rok vydání: 2016
Předmět:
Zdroj: Ophthalmic Surgery, Lasers and Imaging Retina. 47:149-155
ISSN: 2325-8179
2325-8160
DOI: 10.3928/23258160-20160126-08
Popis: BACKGROUND AND OBJECTIVE: To evaluate the effect of a single dose of intravitreal diclofenac on macular edema (ME) due to branch retinal vein occlusion (BRVO). PATIENTS AND METHODS: In this prospective, interventional case series, 15 eyes with BRVO and ME with central macular thickness (CMT) greater than 250 µm on spectral-domain optical coherence tomography (SD-OCT) were enrolled. All patients were given 0.05 mg/0.1 mL of intravitreal diclofenac under aseptic conditions and followed up for 3 months with respect to best-corrected visual acuity (BCVA), intraocular pressure (IOP), fundus fluorescein angiography, and CMT measured on OCT. RESULTS: The mean visual acuity improved from 0.115 ± 0.03 preoperatively to 0.356 ± 0.29 at 3 months ( P = .002). Mean line improvement was 2.2 ± 1.6. Mean preoperative CMT decreased from 453.2 µm ± 55.3 µm to 340.47 µm ± 101 µm at 3 months postoperatively ( P = .001). The mean preoperative IOP was 16.4 mm Hg ± 1.59 mm Hg, whereas the mean postoperative IOP was 16.6 mm Hg ± 1.58 mm Hg ( P = .08). None of the 12 phakic eyes showed evidence of cataract progression. CONCLUSION: Intravitreal diclofenac is safe and effective in improving BCVA and decreasing CMT in patients with BRVO and ME. [ Ophthalmic Surg Imaging Lasers Retina . 2016;47:149–155.]
Databáze: OpenAIRE